ASTORG Partners, French private equity specialist with a specific focus on mid-cap LBO segment, is pleased to announce the appointment of François de Mitry as Partner.
François de Mitry, 46, started his career at CCF in the M&A division in Milan, then, in 1991, joined the Acquisition & Leveraged Finance team at Société Générale. In 1997, he joined Intermediate Capital Group PLC, leading arranger and provider of mezzanine finance for LBO transactions in Europe and listed on the London stock exchange. He was appointed Managing Director in 2005, then progressively responsible for ICG's investment activities in Mezzanine and Equity in Europe and worldwide.In this capacity, he was the ICG representative on the Boards of Directors of several European companies.He also was Chairman of the Supervisory Boards of Gerflor and Eisman. Since 2004, he is a Member of the Supervisory Board of Wendel. François de Mitry is a graduate of IEP Paris and Université de Dauphine Paris IX.
"We are extremely pleased to welcome François de Mitry to the Astorg team, with whom we have had the opportunity to work for the past 15 years on different mezzanine debt and equity co-investments in transactions led by Astorg. François, one the best and most talented European professionals in these fields, co-ran one of the largest mezzanine providers, listed on the London Stock Exchange. He will split his time between Paris and London, and his international experience and in-depth knowledge of the European private equity markets, both on debt and equity components, will be an invaluable asset for Astorg's future growth." declared Xavier Moreno, Chairman and Founding Managing Partner of Astorg.
"I am delighted to join Astorg, renowned for the quality of its investments and experienced management team, its strong historical and continued performance, and its long-term industrial approach to investment. In addition, the successful closing of Astorg's fifth fund in April 2011 opens up significant new growth opportunities in Europe." declared François de Mitry.
Latest news
Astorg-backed CordenPharma acquires AmbioPharm, strengthening its position as a leading global peptide development and manufacturing platform
Healthcare 04 June 2026Astorg-backed Steliau to acquire Acal BFI, strengthening its position as the leading European platform in value-added electronic solutions
Business Services 01 June 2026Astorg to Acquire Global Microbiology Business from Thermo Fisher Scientific
Healthcare 27 April 2026